
We observed a group of outpatients with stage III arterial hypertension having high and very high risk of cardiovascular ailments who received combined antihypertensive therapy with Lisoretic and Presartan. Cardioand nephroprotective effects as well as a target level of arterial pressure were achieved within 10 months under observation.
На амбулаторном этапе лечения наблюдалась группа больных артериальной гипертонией III ст. с высоким и очень высоким сердечно-сосудистым риском, получавшая комбинированную гипотензивную терапию Лизоретиком и Презартаном. В течение 10-месячного наблюдения у больных получен кардиои нефропротекторный эффекты и достигнут целевой уровень АД.
ГИПОТЕНЗИВНАЯ ТЕРАПИЯ, АРТЕРИАЛЬНАЯ ГИПЕРТОНИЯ, ЦЕЛЕВОЙ УРОВЕНЬ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ, КАРДИОПРОТЕКЦИЯ, НЕФРОПРОТЕКЦИЯ
ГИПОТЕНЗИВНАЯ ТЕРАПИЯ, АРТЕРИАЛЬНАЯ ГИПЕРТОНИЯ, ЦЕЛЕВОЙ УРОВЕНЬ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ, КАРДИОПРОТЕКЦИЯ, НЕФРОПРОТЕКЦИЯ
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
